Koninklijke Philips (PHG) Capital Expenditures Growth (3y) (2012 - 2026)

Koninklijke Philips (PHG) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capex Growth (3y) (Qtr)
1	Abbott Laboratories	199.71 Bn	194.11 Bn	7.27 Bn	-0.66%
2	Stryker	127.04 Bn	123.56 Bn	4.50 Bn	9.94%
3	Medtronic	118.81 Bn	109.59 Bn	6.41 Bn	8.89%
4	Boston Scientific	73.18 Bn	72.64 Bn	3.85 Bn	10.89%
5	Edwards Lifesciences	52.03 Bn	47.78 Bn	1.35 Bn	11.78%
6	Dexcom	34.34 Bn	32.39 Bn	830.00 Mn	12.81%
7	GE HealthCare Technologies	33.78 Bn	31.67 Bn	2.18 Bn	12.62%
8	Koninklijke Philips	26.35 Bn	23.03 Bn	4.55 Bn	19.51%
9	Steris	23.03 Bn	22.54 Bn	684.20 Mn	9.52%
10	Zimmer Biomet Holdings	19.18 Bn	18.77 Bn	1.54 Bn	-17.72%

Download Data